kw.\*:("Delavirdina")
Results 1 to 25 of 78
Selection :
Synthesis, biological evaluation, and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptaseSILVESTRI, Romano; ARTICO, Marino; DE MARTINO, Gabriella et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 8, pp 1567-1576, issn 0022-2623Article
Synthesis of novel N-1 (allyloxymethyl) analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine) with improved activity against HIV-1 and its mutantsEL-BROLLOSY, Nasser R; JØRGENSEN, Per T; DAHAN, Berit et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 26, pp 5721-5726, issn 0022-2623, 6 p.Article
Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detectionVELDKAMP, A. I; VAN HEESWIJK, R. P. G; HOETELMANS, R. M. W et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 727, Num 1-2, pp 151-157, issn 1387-2273Article
Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failedBELLMAN, P. C.AIDS (London). 1998, Vol 12, Num 11, pp 1333-1340, issn 0269-9370Article
Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: Probable involvement of CYP2D6 and CYP3AVOORMAN, R. L; MAIO, S. M; HAUER, M. J et al.Drug metabolism and disposition. 1998, Vol 26, Num 7, pp 631-639, issn 0090-9556Article
Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two- and three-drug combinations of delavirdine, lamivudine and zidovudinePAGANO, P. J; CHONG, K. T.Antiviral chemistry & chemotherapy. 1997, Vol 8, Num 4, pp 333-341, issn 0956-3202Article
Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell cultureSTÖRMER, Elke; VON MOLTKE, Lisa L; PERLOFF, Michael D et al.Pharmaceutical research. 2002, Vol 19, Num 7, pp 1038-1045, issn 0724-8741Article
Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detectionREZK, Naser L; TIDWELL, Richard R; KASHUBA, Angela D. M et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 774, Num 1, pp 79-88, issn 1387-2273Article
Pharmacokinetic interaction between amprenavir and delavirdine: Evidence of induced clearance by amprenavirTRAN, Jonathan Q; PETERSEN, Carolyn; GARRETT, May et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 6, pp 615-626, issn 0009-9236, 12 p.Article
Delavirdine: Clinical pharmacokinetics and drug interactionsTRAN, Jonathan Q; GERBER, John G; KERR, Bradley M et al.Clinical pharmacokinetics. 2001, Vol 40, Num 3, pp 207-226, issn 0312-5963Article
The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapyMOYLE, Graeme.Drugs (Basel). 2001, Vol 61, Num 1, pp 19-26, issn 0012-6667Article
Frequency of cutaneous reactions on rechallenge with nevirapine and delavirdineGANGAR, M; ARIAS, G; O'BRIEN, J. G et al.The Annals of pharmacotherapy. 2000, Vol 34, Num 7-8, pp 839-842, issn 1060-0280Article
In situ determination of delavirdine mesylate particle size in solid oral dosage formsWHITE, J. G.Pharmaceutical research. 1999, Vol 16, Num 4, pp 545-548, issn 0724-8741Article
Non-nucleoside reverse transcriptase inhibitors : the NNRTI boomPEDERSEN, O. S; PEDERSEN, E. B.Antiviral chemistry & chemotherapy. 1999, Vol 10, Num 6, pp 285-314, issn 0956-3202Article
Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitorsSHAO, X; RYTTING, A.-S; EKSTRAND, D. H. L et al.Antiviral chemistry & chemotherapy. 1998, Vol 9, Num 2, pp 167-176, issn 0956-3202Article
Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosineCHONG, K.-T; PAGANO, P. J.Antiviral research. 1997, Vol 34, Num 1, pp 51-63, issn 0166-3542Article
Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their ToxicityBLAS-GARCIA, A; ESPLUGUES, J. V; APOSTOLOVA, N et al.Current medicinal chemistry. 2011, Vol 18, Num 14, pp 2186-2195, issn 0929-8673, 10 p.Article
Buprenorphine and HIV primary care: new opportunities for integrated treatmentKHALSA, Jag; VOCCI, Francis J; FIELLIN, David et al.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, 91 p., SUP4Conference Proceedings
Long-term pharmacokinetics of amprenavir in combination with delavirdine in HIV-infected childrenENGELHORN, C; HOFFMANN, F; KUROWSKI, M et al.AIDS (London). 2004, Vol 18, Num 10, pp 1473-1475, issn 0269-9370, 3 p.Article
Pharmacokinetics of ritonavir and delavirdine in human immunodeficiency virus-infected patientsSHELTON, Mark J; HEWITT, Ross G; ADAMS, John et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1694-1699, issn 0066-4804, 6 p.Article
Delavirdine increases drug exposure of ritonavir-boosted protease inhibitorsHARRIS, Marianne; ALEXANDER, Chris; O'SHAUGHNESSY, Michael et al.AIDS (London). 2002, Vol 16, Num 5, pp 798-799, issn 0269-9370Article
Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasmaPROUST, V; TOTH, K; HULIN, A et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 742, Num 2, pp 453-458, issn 1387-2273Article
Delavirdine : A review of its use in HIV infectionSCOTT, Lesley J; PERRY, Caroline M.Drugs (Basel). 2000, Vol 60, Num 6, pp 1411-1444, issn 0012-6667Article
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir : AIDS Clinical Trials Group Study 359GULICK, Roy M; HU, X. Joan; SNYDER, Sally et al.The Journal of infectious diseases. 2000, Vol 182, Num 5, pp 1375-1384, issn 0022-1899Article
Isolation and characterization of simian immunodeficiency virus variants that are resistant to nonnucleoside reverse transcriptase inhibitorsISAKA, Y; MIKI, S; KAWAUCHI, S et al.Archives of virology. 2000, Vol 145, Num 12, pp 2481-2492, issn 0304-8608Article